Latest filing published 28 Jun 2012 for Cytocom, Inc..
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -33.3%Entry US$30.00 · Close at T+365 US$20.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
C. Neil Lyons: trading record in brief
This profile gathers the share dealings of C. Neil Lyons across 2 companies, led by Regenerx Biopharmaceuticals Inc and Cytocom, Inc. Between 29 August 2007 and 26 June 2012, the trades on record add up to 4 filings.
Every open-market trade on record is a purchase: 2 purchases worth €4,695, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 share grants.
The newest entry dates from 28 June 2012: a share grant, in Cytocom, Inc. The last insider purchase was made public on 11 June 2010, 5,995 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to C. Neil Lyons
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,273 shares0Common stock, par value $0.005 per shareSEC:0001171843-12-002423:0
- 5,000 shares@ US$0.2844Common StockSEC:0001209191-10-033910:0Canonical exit: 8 Sept 2010 (T+90)
- 15,000 shares@ US$0.2844Common StockSEC:0001209191-10-033910:1Canonical exit: 9 Sept 2010 (T+90)
- 10,000 shares@ US$1.96Common StockSEC:0001181431-07-055135:0
4 of 4 declarations